tm
Seeing Is Believing
tm
Seeing Is Believing
FWBI is currently covered by 2 analysts with an average price target of $-6.13. This is a potential upside of $-9.11 (-305.7%) from yesterday's end of day stock price of $2.98.
First Wave BioPharma's activity chart (see below) currently has 3 price targets and 13 ratings on display. The stock rating distribution of FWBI is 77.78% BUY and 22.22% HOLD.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 63.5 days.
Highest price target for FWBI is $114, Lowest price target is $4, average price target is $-6.13.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 25-Mar-2024. First documented stock forecast 01-Apr-2021.
Currently out of the existing stock ratings of FWBI, 7 are a BUY (77.78%), 2 are a HOLD (22.22%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
7 months 27 days ago
(25-Mar-2024)
6/6 (100%)
$-22 (-68.75%)
83
Buy
$11
$8.02 (269.13%)
$175
1 years 2 months 2 days ago
(19-Sep-2023)
1/3 (33.33%)
$3.78 (52.35%)
44
What is FWBI (First Wave BioPharma) average time for price targets to be met?
Which analyst has the current highest performing score on FWBI (First Wave BioPharma) with a proven track record?
Which analyst has the current lower performing score on FWBI (First Wave BioPharma) with a proven track record?
Which analyst has the most public recommendations on FWBI (First Wave BioPharma)?
Which analyst is the currently most bullish on FWBI (First Wave BioPharma)?
Which analyst is the currently most reserved on FWBI (First Wave BioPharma)?
